Literature DB >> 24009240

Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall.

Anneleen Pletinck1, Griet Glorieux, Eva Schepers, Gerald Cohen, Bertrand Gondouin, Maria Van Landschoot, Sunny Eloot, Angelique Rops, Johan Van de Voorde, An De Vriese, Johan van der Vlag, Philippe Brunet, Wim Van Biesen, Raymond Vanholder.   

Abstract

Leukocyte activation and endothelial damage both contribute to cardiovascular disease, a major cause of morbidity and mortality in CKD. Experimental in vitro data link several protein-bound uremic retention solutes to the modulation of inflammatory stimuli, including endothelium and leukocyte responses and cardiovascular damage, corroborating observational in vivo data. However, the impact of these uremic toxins on the crosstalk between endothelium and leukocytes has not been assessed. This study evaluated the effects of acute and continuous exposure to uremic levels of indoxylsulfate (IS), p-cresylsulfate (pCS), and p-cresylglucuronide (pCG) on the recruitment of circulating leukocytes in the rat peritoneal vascular bed using intravital microscopy. Superfusion with IS induced strong leukocyte adhesion, enhanced extravasation, and interrupted blood flow, whereas pCS caused a rapid increase in leukocyte rolling. Superfusion with pCS and pCG combined caused impaired blood flow and vascular leakage but did not further enhance leukocyte rolling over pCS alone. Intravenous infusion with IS confirmed the superfusion results and caused shedding of heparan sulfate, pointing to disruption of the glycocalyx as the mechanism likely mediating IS-induced flow stagnation. These results provide the first clear in vivo evidence that IS, pCS, and pCG exert proinflammatory effects that contribute to vascular damage by stimulating crosstalk between leukocytes and vessels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24009240      PMCID: PMC3839540          DOI: 10.1681/ASN.2012030281

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  80 in total

1.  Uraemic toxins for consideration by the cardiologist-Beyond traditional and non-traditional cardiovascular risk factors.

Authors:  Ziad A Massy; Daniela V Barreto; Fellype C Barreto; Raymond Vanholder
Journal:  Atherosclerosis       Date:  2010-05-14       Impact factor: 5.162

Review 2.  New uremic toxins - which solutes should be removed?

Authors:  Griet Glorieux; Raymond Vanholder
Journal:  Contrib Nephrol       Date:  2010-10-07       Impact factor: 1.580

3.  Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.

Authors:  Chien-Te Lee; Chien-Chun Kuo; Yu-Ming Chen; Chung-Yao Hsu; Wen-Chin Lee; Yu-Che Tsai; Hwee-Yeong Ng; Li-Chueh Kuo; Terry Ting-Yu Chiou; Yu-Kun Yang; Ben-Chung Cheng; Jin-Bor Chen
Journal:  Perit Dial Int       Date:  2010-03-25       Impact factor: 1.756

4.  Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation.

Authors:  Zohra Tumur; Hidehisa Shimizu; Atsushi Enomoto; Hitoshi Miyazaki; Toshimitsu Niwa
Journal:  Am J Nephrol       Date:  2010-04-14       Impact factor: 3.754

5.  Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-κB pathway.

Authors:  Natsumi Masai; Junko Tatebe; Gen Yoshino; Toshisuke Morita
Journal:  Circ J       Date:  2010-08-31       Impact factor: 2.993

6.  Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure.

Authors:  Chao-Ping Wang; Li-Fen Lu; Teng-Hung Yu; Wei-Chin Hung; Cheng-An Chiu; Fu-Mei Chung; Lee-Ren Yeh; Han-Jung Chen; Yau-Jiunn Lee; Jer-Yiing Houng
Journal:  Atherosclerosis       Date:  2010-04-04       Impact factor: 5.162

Review 7.  Does uremia cause vascular dysfunction?

Authors:  Philippe Brunet; Bertrand Gondouin; Ariane Duval-Sabatier; Laetitia Dou; Claire Cerini; Françoise Dignat-George; Noémie Jourde-Chiche; Angel Argiles; Stéphane Burtey
Journal:  Kidney Blood Press Res       Date:  2011-06-21       Impact factor: 2.687

8.  Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin.

Authors:  Shunsuke Ito; Mizuko Osaka; Yusuke Higuchi; Fuyuhiko Nishijima; Hideto Ishii; Masayuki Yoshida
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

9.  Salt intake induces epithelial-to-mesenchymal transition of the peritoneal membrane in rats.

Authors:  Anneleen Pletinck; Claudia Consoli; Maria Van Landschoot; Sonja Steppan; Nick Topley; Jutta Passlick-Deetjen; Raymond Vanholder; Wim Van Biesen
Journal:  Nephrol Dial Transplant       Date:  2010-02-11       Impact factor: 5.992

10.  Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?

Authors:  Suree Lekawanvijit; Anastasia Adrahtas; Darren J Kelly; Andrew R Kompa; Bing H Wang; Henry Krum
Journal:  Eur Heart J       Date:  2010-01-04       Impact factor: 29.983

View more
  40 in total

1.  Effect of uraemia on endothelial cell damage is mediated by the integrin linked kinase pathway.

Authors:  Andrea García-Jérez; Alicia Luengo; Julia Carracedo; Rafael Ramírez-Chamond; Diego Rodriguez-Puyol; Manuel Rodriguez-Puyol; Laura Calleros
Journal:  J Physiol       Date:  2014-12-18       Impact factor: 5.182

2.  Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.

Authors:  Johannes Holle; Uwe Querfeld; Marietta Kirchner; Alexandros Anninos; Jürgen Okun; Daniela Thurn-Valsassina; Aysun Bayazit; Ana Niemirska; Nur Canpolat; Ipek Kaplan Bulut; Ali Duzova; Ali Anarat; Rukshana Shroff; Yelda Bilginer; Salim Caliskan; Cengiz Candan; Jerome Harambat; Zeynep Birsin Özcakar; Oguz Soylemezoglu; Sibylle Tschumi; Sandra Habbig; Ebru Yilmaz; Ayse Balat; Aleksandra Zurowska; Nilgun Cakar; Birgitta Kranz; Pelin Ertan; Anette Melk; Karolis Azukaitis; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2019-08-19       Impact factor: 3.714

Review 3.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

4.  Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.

Authors:  Ruben Poesen; Kathleen Claes; Pieter Evenepoel; Henriette de Loor; Patrick Augustijns; Dirk Kuypers; Björn Meijers
Journal:  J Am Soc Nephrol       Date:  2016-05-26       Impact factor: 10.121

Review 5.  Chronic kidney disease and the gut microbiome.

Authors:  Gerren P Hobby; Oleg Karaduta; Giuseppina F Dusio; Manisha Singh; Boris L Zybailov; John M Arthur
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-13

Review 6.  Thrombosis in the uremic milieu--emerging role of "thrombolome".

Authors:  Moshe Shashar; Jean Francis; Vipul Chitalia
Journal:  Semin Dial       Date:  2014-06-24       Impact factor: 3.455

Review 7.  Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.

Authors:  Shunsuke Ito; Masayuki Yoshida
Journal:  Toxins (Basel)       Date:  2014-02-20       Impact factor: 4.546

8.  The intestine and the kidneys: a bad marriage can be hazardous.

Authors:  Raymond Vanholder; Griet Glorieux
Journal:  Clin Kidney J       Date:  2015-02-10

9.  Classification of Uremic Toxins and Their Role in Kidney Failure.

Authors:  Mitchell H Rosner; Thiago Reis; Faeq Husain-Syed; Raymond Vanholder; Colin Hutchison; Peter Stenvinkel; Peter J Blankestijn; Mario Cozzolino; Laurent Juillard; Kianoush Kashani; Manish Kaushik; Hideki Kawanishi; Ziad Massy; Tammy Lisa Sirich; Li Zuo; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2021-07-07       Impact factor: 8.237

10.  Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy.

Authors:  Griet Glorieux; James Tattersall
Journal:  Clin Kidney J       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.